New Solutions for High-Throughput Fluorescent Scanning & Analysis from Aperio ePathology – Free Webinar

Will Howat, PhD Head of Histopathology/ISH Cancer Research UK, Cambridge Institute

To mark the release of the integration of Ariol – which includes versatile FISH scanning and analysis – into the Aperio ePathology solution portfolio, we are pleased to offer an opportunity to hear from a leading expert in imaging and fluorescent scanning. You will learn about how a prominent facility is using fluorescent eSlides to achieve highly accurate data while also increasing the facility’s productivity. Join Dr. Will Howat to learn how to overcome challenges and find new solutions for high throughput fluorescent slide scanning.Complimentary WebinarThursday May 9, 2013 11:00 am Eastern / 15:00

Learn how Dr. Howat is using ePathology solutions including the Ariol system to:

• Increase Throughput -Automated imaging and analysis of biomarkers in tissue sections and microarrays.
• Achieve Reproducible Results – Control & standardize from slide, to image, to report.
• Increase Quality of Data – Capture the maximum information from every sample.
• Remove Bias – Base conclusions on objective, comprehensive data.

Ariol is an automated scanning & image analysis system for the quantification of biomarkers on microscope slides in research, clinical, pharmaceutical, genomic, and proteomic applications. It is capable of both brightfield and fluorescent imaging, and it rapidly scans and quantitates IHC, FISH, Immunofluorescence, Rare Cell, Angiogenesis, Ploidy, and Tissue Micro Array slides.

Ariol is clinically validated in the USA for HER-2/neu, ER, and PR immunohistochemical analysis, Her2 FISH (Abbott) & Micrometastisies detection in Bone Marrow.

Will Howat, PhD
Will Howat graduated with a BSC (Hons) in Immunology & Pharmacology from the University of Strathclyde, then received a PhD in Pathology from the University of Southampton. After two post-doctoral positions in Southampton, he moved to the Wellcome Trust Sanger Institute in Cambridge as the leader of Research & Development for the Immunohistochemistry group of the Atlas of Protein Expressionproject. He joined Cancer Research UK as the head of the Histopathology/ISH facility at the Cancer Research UK Cambridge Institute in 2006, where he heads a team performing routine histopathology, antibody validation, in situ hybridization and digitalimaging & analysis for the research groups within the Institute.

Register to attend this complimentary webinar:

Thursday, May 9, 2013
11:00 am Eastern / 15:00 UTC(GMT)       

Visit www.LeicaBiosystems.com/ePathology to learn more about how pathologists are using Aperio ePathology solutions to connect, collaborate and concur like never before.